BRITS are being urged to look out for symptoms of RSV after an increase in cases of the highly contagious disease. The virus ...

The main market opportunities in the RSV prophylaxis field lie in the development of new monoclonal antibodies and vaccines, with substantial growth expected due to late-stage pipeline products. This ...

People aged 75 to 79, as well as people who turned 80 after 1 September 2024, are eligible for a vaccine to protect against respiratory syncytial virus (RSV). RSV affects the airways and lungs and can ...

Co., Ltd. ("Sanyou Bio") and South Korea's FatiAbGen Co., Ltd. today jointly announced the signing of a comprehensive strategic collaboration agreement covering joint project development, exclusive ...

A new study published in the journal of Arthritis & Rheumatology revealed that patients with rheumatoid arthritis-associated ...

As cold weather sets in, viruses such as influenza, RSV, and COVID-19 are resurfacing. Quickly identifying symptomatic individuals is an essential part of any strategy to fight their spread. Yet, ...